By binding to CYCLINL1 at the m6A site, NEAT1-1 becomes a bridge that connects CYCLINL1 and CDK19 and then phosphorylates pol II Ser2 in the RUNX2 promoter, ultimately promoting the bone metastasis of prostate cancer (PC)58. This evidence concerns the gene CDK19 and pachyonychia congenita.